Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin Oral Gel for Periodontal Pockets
NCT04355416Phase 1Unknown
- Sponsor
- University of Baghdad
- Start
- Apr 2020
- Primary completion
- May 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of curcumin in chronic periodontitis (2 arms), sponsored by University of Baghdad. Primary endpoints: Interleukin-8 Level in Gingival Crevicular Fluid at 1 month, Plaque Index (PLI) at 1 month and 4 more. Status: unknown.
02
Drugs
curcumin
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT04355416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355416.